JP2021500325A5 - - Google Patents

Download PDF

Info

Publication number
JP2021500325A5
JP2021500325A5 JP2020520777A JP2020520777A JP2021500325A5 JP 2021500325 A5 JP2021500325 A5 JP 2021500325A5 JP 2020520777 A JP2020520777 A JP 2020520777A JP 2020520777 A JP2020520777 A JP 2020520777A JP 2021500325 A5 JP2021500325 A5 JP 2021500325A5
Authority
JP
Japan
Prior art keywords
functional
vaccine
live attenuated
bordetella strain
tct
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020520777A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021500325A (ja
JP7335874B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2018/078522 external-priority patent/WO2019077028A1/en
Publication of JP2021500325A publication Critical patent/JP2021500325A/ja
Publication of JP2021500325A5 publication Critical patent/JP2021500325A5/ja
Priority to JP2023089684A priority Critical patent/JP7812352B2/ja
Application granted granted Critical
Publication of JP7335874B2 publication Critical patent/JP7335874B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020520777A 2017-10-18 2018-10-18 血清型3線毛を発現するボルデテラ(bordetella)菌株 Active JP7335874B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023089684A JP7812352B2 (ja) 2017-10-18 2023-05-31 血清型3線毛を発現するボルデテラ(bordetella)菌株

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762574068P 2017-10-18 2017-10-18
US62/574,068 2017-10-18
PCT/EP2018/078522 WO2019077028A1 (en) 2017-10-18 2018-10-18 BORDETELLA STRAINS EXPRESSING SERO-TYPE FIMBRIAE 3

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023089684A Division JP7812352B2 (ja) 2017-10-18 2023-05-31 血清型3線毛を発現するボルデテラ(bordetella)菌株

Publications (3)

Publication Number Publication Date
JP2021500325A JP2021500325A (ja) 2021-01-07
JP2021500325A5 true JP2021500325A5 (https=) 2021-10-07
JP7335874B2 JP7335874B2 (ja) 2023-08-30

Family

ID=64664226

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020520777A Active JP7335874B2 (ja) 2017-10-18 2018-10-18 血清型3線毛を発現するボルデテラ(bordetella)菌株
JP2023089684A Active JP7812352B2 (ja) 2017-10-18 2023-05-31 血清型3線毛を発現するボルデテラ(bordetella)菌株

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023089684A Active JP7812352B2 (ja) 2017-10-18 2023-05-31 血清型3線毛を発現するボルデテラ(bordetella)菌株

Country Status (8)

Country Link
US (2) US11446372B2 (https=)
EP (1) EP3697439A1 (https=)
JP (2) JP7335874B2 (https=)
CN (2) CN118979003A (https=)
AU (1) AU2018353409B2 (https=)
CA (1) CA3077428A1 (https=)
SG (1) SG11202003333WA (https=)
WO (1) WO2019077028A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9119804B2 (en) 2006-03-10 2015-09-01 Institut Pasteur De Lille Live attenuated bordetella strains as a single dose vaccine against whooping cough
SG175803A1 (en) 2009-04-28 2011-12-29 Pasteur Institut Vaccine for prophylaxis or treatment of an allergen-driven airway pathology
SG11202003333WA (en) * 2017-10-18 2020-05-28 Pasteur Institut Bordetella strains expressing serotype 3 fimbriae
EP4247397A4 (en) 2020-11-17 2024-11-06 Iliad Biotechnologies, LLC TREATMENT AND PREVENTION OF NEUROPATHOLOGY ASSOCIATED WITH NEURODEGENERATIVE DISEASES

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4883761A (en) * 1986-03-25 1989-11-28 The United States Of America As Represented By The Department Of Health And Human Services Pertussis toxin gene: cloning and expression of protective antigen
US6713072B1 (en) 1987-11-02 2004-03-30 Chiron S.R.L. Immunologically active polypeptides with altered toxicity useful for the preparation of an antipertussis vaccine
IT1236971B (it) * 1989-11-03 1993-05-07 Eniricerche Spa Regione promotore dei geni codificanti le subunita' piliniche fim2, fm3 e fimx di bordetella pertussis e loro impiego per l'espressione di geni che codificano una proteina di interesse.
GB9115332D0 (en) 1991-07-16 1991-08-28 Connaught Lab Manipulation of gene copy number in bordetella
FR2718750B1 (fr) 1994-04-19 1996-06-14 Pasteur Institut Protéines recombinantes de l'hémagglutinine filamenteuse de Bordetella, notamment, B. Pertussis, production et application à la production de protéines étrangères ou de principes actifs vaccinants.
FR2754543B1 (fr) * 1996-10-11 1998-12-31 Pasteur Institut Souche de bordetella deficiente dans la production de toxine et exprimant une proteine hydride, liposomes comprenant de la fha et leurs utilisations comme vaccins, et utilisation de la fha pour stimuler les reponses immunitaires
FR2840319B1 (fr) 2002-05-30 2004-08-20 Pasteur Institut Souches de bordetella rendues deficientes par attenuation genetique
EP1617805A4 (en) 2003-04-11 2012-07-04 Medimmune Llc METHODS FOR PREVENTING OR TREATING RESPIRATORY CONDITIONS
GB0402131D0 (en) * 2004-01-30 2004-03-03 Isis Innovation Delivery method
US9119804B2 (en) * 2006-03-10 2015-09-01 Institut Pasteur De Lille Live attenuated bordetella strains as a single dose vaccine against whooping cough
CA2669485C (en) 2006-11-15 2017-01-03 Folia Biotech Inc. Papaya mosaic virus-based vaccines for influenza
EP2134359A4 (en) 2007-02-23 2010-06-16 Penn State Res Found USE OF A NONVIRULENT BORDETELLA MUTANT AS LIVING VACCINE VECTOR
CN100537767C (zh) * 2007-04-29 2009-09-09 中国药品生物制品检定所 百日咳疫苗保护性抗原的重组表达及其应用
WO2008156753A1 (en) 2007-06-18 2008-12-24 Hemispherx Biopharma Early intervention of viral infections with immune activators
SG175803A1 (en) 2009-04-28 2011-12-29 Pasteur Institut Vaccine for prophylaxis or treatment of an allergen-driven airway pathology
DK2442826T3 (en) 2009-06-15 2015-09-21 Univ Singapore Influenza vaccine, composition and methods of using
DK2773371T3 (da) * 2011-11-02 2020-03-09 Nat Univ Singapore Virkning af en svækket bordetella-stamme mod allergisk sygdom
AU2013301312A1 (en) * 2012-08-06 2015-03-19 Glaxosmithkline Biologicals S.A. Method for eliciting in infants an immune response against RSV and B. pertussis
EP2722338A1 (en) * 2012-10-17 2014-04-23 INSERM (Institut National de la Santé et de la Recherche Médicale) Novel recombinant Bordetella strains
US9655959B2 (en) * 2014-10-01 2017-05-23 National University Of Singapore Adenylate cyclase deficient bordetella strains
EP4541809A3 (en) 2016-03-29 2025-06-25 Institut Pasteur de Lille Mutant bordetella strains and methods of use
US10799573B2 (en) * 2016-03-30 2020-10-13 Regents Of The University Of Minnesota Pertussis vaccines and methods of making and using
US20200171169A1 (en) * 2017-05-15 2020-06-04 Vanderbilt University LONG-CIRCULATING ZWITTERIONIC POLYPLEXES FOR siRNA DELIVERY
CN111032078A (zh) * 2017-07-18 2020-04-17 血清研究所印度私人有限公司 具有改善的稳定性、增强的免疫原性和降低的反应原性的免疫原性组合物及其制备方法
SG11202003333WA (en) * 2017-10-18 2020-05-28 Pasteur Institut Bordetella strains expressing serotype 3 fimbriae
US12036405B2 (en) * 2018-03-23 2024-07-16 The Board Of Regents Of The University Of Oklahoma System and method of electric-induced acoustic tomography for electrotherapy monitoring
WO2020049133A1 (en) 2018-09-05 2020-03-12 National University Of Singapore Adenylate cyclase catalytic domain deficient bordetella strains

Similar Documents

Publication Publication Date Title
JP2021500325A5 (https=)
JP2019001815A5 (https=)
Felix et al. Virulence and immunogenic activities of B. typhosus in relation to its antigenic constituents
HRP20191344T1 (hr) Sastavi koji sadrže bakterijske sojeve
JP2016539119A5 (https=)
WO2019077028A4 (en) Bordetella strains expressing serotype 3 fimbriae
CN101600455B (zh) 预防性结核疫苗
Soane et al. Interaction of Bordetella pertussis with human respiratory mucosa in vitro
JP2023109996A5 (https=)
FI3436034T3 (fi) Mutantteja bordetella-kantoja ja käyttömenetelmiä
DE3855442T2 (de) Verfahren zur Gewinnung von Schutzantigenen gegen Bordetella-Infektionen und toxische Prozesse
Apicella et al. Fimbriation of Haemophilus species isolated from the respiratory tract of adults
CN101816783B (zh) 一种表达hbha-il-12融合蛋白的重组耻垢分枝杆菌疫苗
De Moreno de LeBlanc et al. Oral administration of L. casei CRL 431 increases immunity in bronchus and mammary glands
van den Berg et al. Protection and humoral immune responses against Bordetella pertussis infection in mice immunized with acellular or cellular pertussis immunogens
CN110257274B (zh) 一种伪结核棒状杆菌致弱方法及应用
DK202470280A1 (en) Vaccines against moritella viscosa
CN115074286B (zh) 一株拮抗足癣病原真菌的短小芽孢杆菌及其应用
Anderson et al. Experimental mycoplasma mastitis in mice
RU2011109220A (ru) Композиции, содержащие lactobacillus casei для улучшения устойчивости к распространенным инфекционным заболеваниям
CN101721692A (zh) 一种非致病性迟缓爱德华氏菌的应用
HK40115864A (zh) 表达血清3型菌毛的鲍特菌属菌株
Choi et al. Intranasal administration model for evaluating protection against influenza virus in mice
RU2339389C2 (ru) Способ профилактики назофарингиального носительства патогенной микрофлоры
Robson et al. Immunity in Mycobacterium lepraemurium infections